- Home
- UPB vs THW Comparison
UPB vs THW Comparison
Compare UPB & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- THW
- Stock Information
- Founded
- UPB 2021
- THW 2015
- Country
- UPB United States
- THW United States
- Employees
- UPB N/A
- THW N/A
- Industry
- UPB
- THW Finance Companies
- Sector
- UPB
- THW Finance
- Exchange
- UPB NYSE
- THW Nasdaq
- Market Cap
- UPB 457.2M
- THW 454.0M
- IPO Year
- UPB 2024
- THW N/A
- Fundamental
- Price
- UPB $7.98
- THW $12.00
- Analyst Decision
- UPB Strong Buy
- THW
- Analyst Count
- UPB 4
- THW 0
- Target Price
- UPB $56.50
- THW N/A
- AVG Volume (30 Days)
- UPB 245.5K
- THW 149.9K
- Earning Date
- UPB 03-04-2025
- THW 01-01-0001
- Dividend Yield
- UPB N/A
- THW 10.76%
- EPS Growth
- UPB N/A
- THW N/A
- EPS
- UPB N/A
- THW N/A
- Revenue
- UPB $2,207,000.00
- THW N/A
- Revenue This Year
- UPB N/A
- THW N/A
- Revenue Next Year
- UPB N/A
- THW N/A
- P/E Ratio
- UPB N/A
- THW N/A
- Revenue Growth
- UPB 82.10
- THW N/A
- 52 Week Low
- UPB $6.65
- THW $9.76
- 52 Week High
- UPB $29.46
- THW $14.89
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- THW 56.72
- Support Level
- UPB N/A
- THW $11.85
- Resistance Level
- UPB N/A
- THW $12.03
- Average True Range (ATR)
- UPB 0.00
- THW 0.13
- MACD
- UPB 0.00
- THW -0.00
- Stochastic Oscillator
- UPB 0.00
- THW 48.72
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas.